Keith T. Flaherty, Director at Loxo Oncology, Inc. (LOXO), sold 14,500 shares at $75.35 ($1.1M) on 2017-11-20, disclosed to the SEC on 2017-11-22.
Open-market sale of $1.1M LOXO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.35 | 4,489 | $338K | 30.7% |
| 2 | $75.35 | 4,489 | $338K | 30.7% |
| 3 | $76.29 | 800 | $61K | 5.5% |
| 4 | $76.29 | 800 | $61K | 5.5% |
| 5 | $77.33 | 1,961 | $152K | 13.8% |
| 6 | $77.33 | 1,961 |
| $152K |
| 13.8% |
| Total | $75.99 avg | 14,500 | $1.1M | 100% |
| Filing → |
| LOXO | SELL | 2017-05-24 | $649K | — | Filing → |
| LOXO | SELL | 2017-02-23 | $601K | — | Filing → |
| LOXO | SELL | 2016-12-21 | $438K | — | Filing → |